Literature DB >> 6251140

Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay.

E M Salonen, A Vaheri, J Suni, O Wager.   

Abstract

IgM rheumatoid factor (RF), an autoantibody to the Fc fragment of IgG, was determined by solid-phase enzyme immunoassay (EIA). RF levels were significantly higher in patients with rubella virus infection than in patients with infections due to influenza virus, cytomegalovirus, respiratory syncytial virus, parainfluenza virus, adenovirus, mumps virus, or herpes simplex virus. To evaluate the role of RF in EIA determinations of viral antibodies, IgM RF from IgM-IgG cryoglobulin or control IgM was added to patient sera before assay for viral antibodies. IgM RF inhibited virus-specific IgG and IgA reactions and gave nonspecific IgM reactions in EIA for antibodies to rubella and influenza viruses, but had little or no effect on antibodies to cytomegalovirus. The minimal effective amounts of RF were 100-500 ng/ml for inhibition of IgG, 300-1,000 ng/ml for IgA, and 25-500 ng/ml for IgM. The control IgM preparation gave no such effects. These studies reinforce the need to eliminate RF interference in solid-phase EIA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251140     DOI: 10.1093/infdis/142.2.250

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  T Cell-Dependent Affinity Maturation and Innate Immune Pathways Differentially Drive Autoreactive B Cell Responses in Rheumatoid Arthritis.

Authors:  Daniel R Lu; Andrew N McDavid; Sarah Kongpachith; Nithya Lingampalli; Jacob Glanville; Chia-Hsin Ju; Raphael Gottardo; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2018-09-24       Impact factor: 10.995

2.  Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

Authors:  T Zhang; C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Evaluation of a new commercial enzyme immunoassay for the detection of IgM antibodies to West Nile virus using a ratio method to eliminate nonspecific reactivity.

Authors:  Ryan J Welch; Brian L Anderson; Christine M Litwin
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

4.  Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay.

Authors:  B Niklasson; T Kjelsson
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

5.  Specific serum immunoglobulin D, detected by antibody capture enzyme-linked immunosorbent assay (ELISA), in cytomegalovirus infection.

Authors:  J Mortensen; S L Nielsen; I Sørensen; H K Andersen
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

6.  Detection of specific immunoglobulin M antibodies to cytomegalovirus by using monoclonal antibody to immunoglobulin M in an indirect immunofluorescence assay.

Authors:  M Zerbini; M Musiani; G Gentilomi; M La Placa
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

7.  Detection of specific immunoglobulin M antibody to rubella virus by use of an enzyme-labeled antigen.

Authors:  C Bonfanti; O Meurman; P Halonen
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

8.  Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles.

Authors:  A W Lievens; P A Brunell
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

9.  Assay of measles virus IgM and IgG class antibodies by use of peroxidase-labelled viral antigens.

Authors:  J Salonen; R Vainionpää; P Halonen
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

10.  Serological differentiation between acute (late control) and endocarditis Q fever.

Authors:  F Soriano; M T Camacho; C Ponte; P Gómez
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.